BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 629046)

  • 1. Genetic polymorphism of the fourth component of human complement.
    Mauff G; Bender K; Fischer B
    Vox Sang; 1978; 34(5):296-301. PubMed ID: 629046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetic polymorphism of the fourth component of human complement: methodological aspects and a presentation of linkage and association data relevant to its localization in the HLA region.
    Teisberg P; Olaisen B; Jonassen R; Gedde-Dahl T; Thorsby E
    J Exp Med; 1977 Nov; 146(5):1380-9. PubMed ID: 925607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited structural polymorphism of the fourth component of human complement.
    Awdeh ZL; Alper CA
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3576-80. PubMed ID: 6932037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two HLA-linked loci controlling the fourth component of human complement.
    O'Neill GJ; Yang SY; Dupont B
    Proc Natl Acad Sci U S A; 1978 Oct; 75(10):5165-9. PubMed ID: 368809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of complement C4. Two homoduplication haplotypes C4S C4S and C4F C4F in a family.
    Bruun-Petersen G; Lamm LU; Jacobsen BK; Kristensen T
    Hum Genet; 1982; 61(1):36-8. PubMed ID: 7129423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different HLA antigen associations for the functionally active and inactive products of the complement C4F1 allele.
    O'Neill GJ; Miniter P; Pollack MS; Dupont B
    Hum Immunol; 1980 Jul; 1(1):23-30. PubMed ID: 7263310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The C4 system: formal and population genetics.
    Olaisen B; Teisberg P; Jonassen R; Gedde-Dahl T
    Hum Genet; 1979; 50(2):187-92. PubMed ID: 511133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism of the fourth complement component in the dog.
    Doxiadis G; Rebmann V; Doxiadis I; Krumbacher K; Vriesendorp HM; Grosse-Wilde H
    Immunobiology; 1985 Jul; 169(5):563-9. PubMed ID: 4043992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Polymorphism of C4 and factor B in type I diabetes].
    Blickle JF; Hauptmann G; Goetz J; Tongio MM; Mayer S; Brogard JM; Dorner M
    Pathol Biol (Paris); 1988 Jun; 36(6):791-4. PubMed ID: 3047638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C4 allotyping distinguishes HLA-B14.1 and B14.2 subgroups.
    O'Neill GJ; Mueller-Eckhardt G; Prel L; Schendel DJ
    Immunogenetics; 1984; 19(4):335-41. PubMed ID: 6585348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of human C4 polymorphism: detection and segregation of rare and duplicated haplotypes.
    Rittner C; Giles CM; Roos MH; Démant P; Mollenhauer E
    Immunogenetics; 1984; 19(4):321-33. PubMed ID: 6201442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human MHC class III genes, Bf and C4. Polymorphism, complotypes and association with MHC class I genes in the Finnish population.
    Partanen J; Koskimies S
    Hum Hered; 1986; 36(5):269-75. PubMed ID: 3639058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complement markers Bf and C4 in multiple sclerosis].
    Fauchet R; Madigand M; Gueguen-Duchesne MY; Papin J; Sabouraud O; Genetet B
    Rev Neurol (Paris); 1984; 140(6-7):422-5. PubMed ID: 6611572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphism of the fourth component of complement and type 1 (insulin-dependent) diabetes.
    Marcelli-Barge A; Poirier JC; Schmid M; Deschamps I; Lestradet H; Prevost P; Hors J
    Diabetologia; 1984 Jul; 27 Suppl():116-7. PubMed ID: 6332752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High resolution electrophoresis for the allotyping of human C4. Proposal of a relational nomenclature.
    Kölble K; Rukavina V; Kalden JR
    J Immunol Methods; 1987 Jan; 96(1):69-76. PubMed ID: 3492559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inherited polymorphism of guinea pig factor B and C4: evidence for genetic linkage between the C4 and Bf loci.
    Bitter-Suermann D; Krönke M; Brade V; Hadding U
    J Immunol; 1977 May; 118(5):1822-6. PubMed ID: 858918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA and hypocomplementemia: the disadvantage of carrying the HLA-B35 and the silent alleles of the C4 complement component.
    Zorzetto M; Ricevuti G; Martinetti M; Gritti D; Gasparetto C; De Silvestri A; Salvaneschi L; Cuccia M
    Int J Immunopathol Pharmacol; 2004; 17(3):307-16. PubMed ID: 15461865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis: immunogenetic analyses of sib-pair double case families. II. Studies on the association of multiple sclerosis with C2, C4, BF, C3, C6, and GLO polymorphisms.
    Schröder R; Zander H; Andreas A; Mauff G
    Immunobiology; 1983 Mar; 164(2):160-70. PubMed ID: 6552216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA polymorphism of human HLA-linked complement C4 allotypes, including C4 null alleles, in the Finnish population.
    Partanen J; Peltonen L; Koskimies S; Carroll MC
    Hum Hered; 1987; 37(4):241-9. PubMed ID: 2888726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA and C4 polymorphism in diabetic microangiopathy.
    Fletcher JA; Mijovic C; Barnett AH; Bradwell AR; Delamere J; Milles J; Wells L; Jobson S; Mackintosh P
    Diabetes Res; 1987 Feb; 4(2):101-2. PubMed ID: 3495390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.